SCHEMBL9595260

SCHEMBL9595260

COc1ccc2c(Nc3cccc(CO)c3)c3cc(OC)c(OC)cc3nc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 1/20 0.58
▸ TOP2B Q02880 1/20 0.58
▸ KDM1A O60341 4/20 0.47
▸ PDPK1 O15530 1/20 0.47
▸ CYP19A1 P11511 1/20 0.46
▸ RET P07949 2/20 0.45
▸ KDR P35968 2/20 0.45
▸ SRC P12931 1/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ PHLPP2 Q6ZVD8 2/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ RAD52 P43351 1/20 0.43
▸ GFER P55789 1/20 0.43
▸ EGFR P00533 4/20 0.43
▸ ERBB2 P04626 2/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ FGFR1 P11362 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9595086 0.94 TOP2A (0.58) TOP2ATOP2BKDM1APDPK1CYP19A1
SCHEMBL9594095 0.93 TOP2A (0.66) TOP2ATOP2BKDM1ACYP19A1KMT2A
SCHEMBL9593205 0.93 TOP2A (0.55) TOP2ATOP2BKDM1APDPK1CYP19A1
SCHEMBL9594317 0.93 TOP2A (0.55) TOP2ATOP2BKDM1APDPK1CYP19A1
SCHEMBL9595683 0.92 TOP2A (0.64) TOP2ATOP2BPDPK1RETKDR
SCHEMBL9594311 0.91 TOP2A (0.64) TOP2ATOP2BKDM1ACYP19A1KMT2A
SCHEMBL9595752 0.89 TOP2A (0.58) TOP2ATOP2BKDM1APDPK1RET
SCHEMBL9595379 0.89 TOP2A (0.58) TOP2ATOP2BKDM1ACYP19A1KMT2A
SCHEMBL9592886 0.89 TOP2A (0.75) TOP2ATOP2BKDM1ACYP19A1KMT2A
SCHEMBL9595077 0.88 TOP2A (0.59) TOP2ATOP2BKDM1ACYP19A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 — — WO claimed
US-5229395-A Potential anticancer agents derived from acridine SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-07-20 — — US disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 — — WO disclosed
Send feedback